Logo image
Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
Journal article   Open access   Peer reviewed

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody

Manish Suneja and Sarat Kuppachi
Clinical kidney journal, Vol.5(3), pp.254-256
06/2012
DOI: 10.1093/ckj/sfs042
PMCID: PMC4400515
PMID: 26069779
url
https://doi.org/10.1093/ckj/sfs042View
Published (Version of record) Open Access

Abstract

Detection of donor-specific human leukocyte antigen (HLA) antibodies is an important part of diagnosis of antibody-mediated rejection (AMR) in the renal transplant population. Donor-specific antibodies (DSA) against HLA-C, a Class 1 major histocompatibility gene product, are not considered to be of major importance in renal transplant rejection. Typing for HLA-C is not a routine part of pre- and post-transplant evaluation. In roughly 10% of biopsy-proven C4d-positive rejections, DSA are not detected by standard testing protocols. In some of these cases, minor HLA and non-HLA antibodies have been implicated. The role of HLA-C antibodies in this patient group is not clear. We present a patient with acute renal graft dysfunction 21 months post-transplant. The allograft biopsy showed features of AMR with diffuse margination of inflammatory cells and diffuse C4d staining in peritubular capillaries. HLA-Cw17 antibody was detected by single-bead antigen Luminex assay, which was further confirmed by a mock flow crossmatch. This case highlights the importance of checking anti-HLA-Cw antibodies in patients with AMR and no detectable DSA using standard methods.
kidney transplant HLA-Cw17 single-antigen bead assay antibody-mediated rejection crossmatch

Details

Metrics

Logo image